Lecture 5 Flashcards

1
Q

Outcome definition

A

results, conditions or events associated with individual study patients that are used to assess study treatement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

primary outcomes

A

assess the main effect of an intervention and drive conclusions about the effectiveness of the intervention under study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

secondary outcomes

A

evaluate additional effects of intervention (side effects, cost)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

effect size

A

difference between the value of the “success” varible (primary outcome) in the control group and that in the test group
-expressed as absolute difference or relative difference
-estimate effect size from previous studies
-large effect size needs smaller sample size
-small effect size needs larger sample size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

clinical outcome

A

directly measures patient health or well being (morbidity/mortality)
-true picture
-can be difficult to measure, long term effect
-example: patient is cancer free for 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

surrogate outcome

A

laboratory measurement or physical sign used as a substitute for clinically meaningful outcome
-need smaller sample size, shorter duration, lower cost
-may not be valid prediction of clinial outcome
-example: tumor regression in patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

selective reporting of outcomes (3)

A

-subset of study outcomes (not all outcomes reported)
-selective reporting of specific outcome (one outcome at one time point is reported, not all)
-incomplete reporting of specific outcome (difference in means reported without CI or standard error)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

selection of outcomes (six questions to ask)

A

-why this outcome (matches obkective of study)
-what health condition and population (ie severity)
-How outcome will be measured (valid, reliable, feasible)
-who appropriate source of information (physician, patient, proxy, reseacher)
-where location of outcome measurement (at home, in doctor office, hospital)
-When responsiveness of measure (take into consideration ability of instrument to detect change over time for the measured construct)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

four key properties of outcome

A

-validity
-reliability
-feasibility
-responsiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Adaptive design

A

allows for prospectively planned modifications to one or more aspects of the design based on acumulating data from subjects
-can lead to unplanned changes based on results or protocol amendments based on external sources
-can adapt: patient pop, sample size, treatement arm selection, patient allocation, endpoint, statistical aspects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

benefits of study adaptation (3)

A

-statistical efficieny (greater chance of detecing drug effect at expected sample size)
-ethical (stop trial if drug not effective, or enough evidence of beneficial effect)
-understanding drug effects (improves estimation of dose-response relationship with adaptive dose selection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

limitations of study adaptation (3)

A

-methodology challenges in controlling bias, reliability and estimation of treatment effects
-operational challenges to maintain study integrity
-interpretability challenges due to changes in estimand of interest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

toxicology definition

A

study of adverse effects of foreign compunds on living organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

adverse effect definition

A

undesrieed harmful effect resulting from medication use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

toxicity

A

capacity of chemical to cause injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

toxicant definition

A

compound foreign to human body

17
Q

five classifications of ADRs

A

type A: predictable, acute, related to mechanism of action (dose, not usually leathal, known effect of drug)
type B: unpredictable, acute/subacute, not related to mechanism, idiosyncratic (unsual) (rarer, more lethal, independent of dose)
type C: chronic effects (drug used for long period of time causes ADR)
type D: Delayed effects (carcinogenic or teratogenic effect, very rare due to extensive testing for delayed effects)
Type E: End of treatement effects (withdrawal effects)

18
Q

drug potentiation

A

drugs with similar actions taken together have additive effect

19
Q

drug displacement

A

two drugs compete for same binding site on receptor
-“loser” will have higher thena normal blood concentration

20
Q

Anatagonism interaction

A

one drug decreases effectivness of another via chemical reaction

21
Q

CYP inducers and inhibitors

A

inducers increase metabolism of drugs requiring the enzyme (inrease breakdown of active drug, decrese effects)
inhibitors reduce metabolism “ “ (increase plasma levels, increase effects)

22
Q

Food

A

food can increase absorption in stomach
-some foods/vitamins interfere with drug metabolism and efficacy